News
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
Vaxcyte said its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a competition with Pfizer and Merck
More in Health
- Burnham urged to ‘end cycle of harm’ after scale of child-on-child sexual abuse revealed The Guardian — Society
- STAT+: Lilly’s Jaypirca approved as first-line CLL therapy STAT
- Republicans and Democrats find a unifying target: Pharmacy benefit managers NPR — Health
- Early Lampard findings could come within weeks BBC News — Health
- Dying Patients Are Inundated by Misinformation. My Dad Was One of Them. The New York Times — Health